The abstract is read at the publisher; the summary is JClub's.
Routine referral to a cardiovascular specialist in prostate cancer patients improved the hierarchical cardiovascular win ratio to 1.60, mainly by lowering cholesterol.
- Why it matters: Prostate cancer patients often have cardiovascular risk factors that are not well controlled, and it is unclear whether systematic specialist-led management improves outcomes beyond usual care.
- What they did: In a randomized clinical trial across 55 sites in 8 countries (2015–2025), patients received usual care plus referral to an internist or cardiologist implementing protocol targets, including systolic blood pressure ≤130 mm Hg and statin use.
- The result: Over median 5.8 years, cholesterol was lower by 12 mg/dL with greater protocol-mandated statin use, but time to cardiovascular death, myocardial infarction, stroke, or heart failure did not differ (subdistribution hazard ratio 1.08).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.